YIDU TECH (02158): Its subsidiary won the bid for the Beijing Cancer Hospital's artificial intelligence construction project in partnership with Yinlai.

YIDU TECH (02158) has announced that its subsidiary MediCloud (Beijing) Technology Co., Ltd. recently won the bid for the Beijing Cancer Hospital artificial intelligence construction Silver Medical collaboration project, with a total amount of approximately 4.88 million RMB. YIDU TECH is the core driving force behind the intelligent upgrade of the Chinese healthcare system. The company empowers the entire industry chain of "medical, pharmaceutical, insurance, and patients" with intelligent decision-making, aiming to bring precise medical care to everyone. By simulating the clinical decision-making logic of doctors, training on the real disease development process, and repeatedly verifying in the real world, the company has created "AI that truly understands diseases" and provides measurable value for the key links in the medical ecosystem: enabling doctors to have more precise and efficient decision-making tools, helping pharmaceutical companies shorten the distance from molecule to patient, allowing patients to access more affordable precise diagnostics and treatments, and providing more scientific support to the public healthcare system. YIDU TECH, with its system-level intelligent innovation, is creating a more resilient, caring, inclusive, and efficient future for medical health.